3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
17
Oropharyngeal Neoplasms
11
Nasopharyngeal Carcinoma
11
Prostatic Neoplasms
7
Laryngeal Neoplasms
7
Mouth Neoplasms
6
Hypopharyngeal Neoplasms
6
Carcinoma
6
Rectal Neoplasms
5
Head and Neck Neoplasms
5
Esophageal Neoplasms
3
Carcinoma, Squamous Cell
3
Carcinoma, Non-Small-Cell Lung
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Salivary Gland Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Nasopharyngeal Neoplasms
2
Mesothelioma
2
Epstein-Barr Virus Infections
2
Astrocytoma
2
Anus Neoplasms
2
Vaginal Neoplasms
1
Urothelial Carcinoma of the Bladder
1
Tongue Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Stomatitis
1
Stomach Neoplasms
1
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
1
Sarcoma
1
Interventions
pembrolizumab
3
lenvatinib
2
Specimen Handling
2
Nivolumab
2
Cisplatin
2
trastuzumab deruxtecan
1
tivozanib
1
liposomal doxorubicin
1
entinostat
1
dostarlimab
1
bintrafusp alfa protein, human
1
atezolizumab
1
Therapeutic Touch
1
Surveys and Questionnaires
1
Radiotherapy
1
Radiation
1
Platinum
1
Paclitaxel
1
Nelfinavir
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Gemcitabine
1
Doxorubicin
1
Dehydroepiandrosterone
1
CTLA-4 Antigen
1
Bupropion
1
Blood Specimen Collection
1
Bevacizumab
1
Axitinib
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Vulvar Neoplasms
×
Radiotherapy, Intensity-Modulated
×
90 days
×
Clear all
No trials found.